Implementing PrEP to Decrease HIV Transmission Rates Among Females

In 2018, 5.1 per 100,000 persons in the United States assigned females at birth (AFAB) were living with human immunodeficiency virus (HIV). HIV prevention tools, including daily oral pre-exposure prophylaxis (PrEP), screening for sexually transmitted infections, treatment, and sexual health counseling, can be implemented into clinical practice to address prevalence of infection among this population. Historically, population has had a decreased opportunity screened or offered PrEP protect them from HIV. Providers incorporate as standard preventative option their AFAB.